Assisted Reproductive Technology Market 2018 Global Size, Industry Analysis, Emerging Technologies, Regional Trends, Competitive Landscape, Future Plans and Opportunity Assessment by Forecast 2023
Assisted Reproductive Technology Market from Qurate Business Intelligence provides detailed information, in depth analysis and forecast which is developed by team of experts and professionals.
(EMAILWIRE.COM, September 15, 2018 ) The Global Assisted Reproductive Technology market was valued at USD 21.9 Billion in 2016, and is projected to reach USD 36.7 billion by 2025, growing at a CAGR of 6% over the forecast period.
Key players: Overview of market leaders in assisted reproductive technology market by top manufacturers/players, with revenue (Billion USD) and market share for each manufacturer/player. The top players including Esco Micro Pte. Ltd. (Esco Group), Hamilton Thorne, Inc, CooperSurgical, Laboratoire CCD, Irvine Scientific, Vitrolife AB, Merck KGaA, Nidacon International AB, Nikon Corporation and IncPlaner PLC.
Get Sample Copy of This Report@ www.qurateresearch.com/report/sample/HnM/QBI-XPR-HnM-55947
Increase in the number of smokers is also anticipated to increase the patient base. Introduction of enhanced technologies for upgrading the outcomes are also expected to increase the market growth over the forecast period. For instance, in August 2015, a treatment method developed by Ovascience’s named as AUGMENT was reported to rejuvenate the eggs of aging women’s and benefit the poor quality eggs.
According to the WHO, the rate of fertility per woman has reduced from five in 1960 to 2.5 in 2012. The declining rates of fertility and increasing stress levels are causing physiological problems which have induced a demand for ART procedures, hence, escalating the market growth. Furthermore, encouraging government and various private organization’s policies for the application of technology is also aiding to the market growth over the forecast period.
Buy This Report@ www.qurateresearch.com/report/buy/HnM/QBI-XPR-HnM-55947/ (Priced at USD 4199)
The report includes -
Segmentation: Based on technology segment, the report segregates the segment and delivers the revenue, growth rate, and market share, of each type,
• In-vitro Fertilization
• Artificial Insemination
• Surrogacy
• Others
On the basis on the procedure, this report focuses on the status and outlook for major applications, market share and growth rate for each application, including
• Frozen Donor
• Frozen Non Donor
• Fresh Donor
• Fresh Non Donor
• Embryo Banking
On the basis of end-user, the market has been segmented further, and displays growth rate and market share over the forecast period;
• Fertility Clinics
• Hospitals
• Others
Enquiry about Report@ www.qurateresearch.com/report/enquiry/HnM/QBI-XPR-HnM-55947
Geographic Segmentation: This report split global market into North America, Europe, Asia Pacific, the Middle East and Africa and Latin America, with revenue (Billion USD), market share and growth rate of assisted reproductive technology for these regions, from 2015 to 2025 (forecast)
• North America: U.S., Rest of North America
• Europe: Germany, France, UK, rest of Europe
• Asia Pacific: China, Japan, India and Rest of Asia Pacific
• Middle East & Africa: GCC, North Africa, South Africa and Rest of MEA
• Latin America: Brazil and Rest of Latin America
Key players: Overview of market leaders in assisted reproductive technology market by top manufacturers/players, with revenue (Billion USD) and market share for each manufacturer/player. The top players including Esco Micro Pte. Ltd. (Esco Group), Hamilton Thorne, Inc, CooperSurgical, Laboratoire CCD, Irvine Scientific, Vitrolife AB, Merck KGaA, Nidacon International AB, Nikon Corporation and IncPlaner PLC.
Get Sample Copy of This Report@ www.qurateresearch.com/report/sample/HnM/QBI-XPR-HnM-55947
Increase in the number of smokers is also anticipated to increase the patient base. Introduction of enhanced technologies for upgrading the outcomes are also expected to increase the market growth over the forecast period. For instance, in August 2015, a treatment method developed by Ovascience’s named as AUGMENT was reported to rejuvenate the eggs of aging women’s and benefit the poor quality eggs.
According to the WHO, the rate of fertility per woman has reduced from five in 1960 to 2.5 in 2012. The declining rates of fertility and increasing stress levels are causing physiological problems which have induced a demand for ART procedures, hence, escalating the market growth. Furthermore, encouraging government and various private organization’s policies for the application of technology is also aiding to the market growth over the forecast period.
Buy This Report@ www.qurateresearch.com/report/buy/HnM/QBI-XPR-HnM-55947/ (Priced at USD 4199)
The report includes -
Segmentation: Based on technology segment, the report segregates the segment and delivers the revenue, growth rate, and market share, of each type,
• In-vitro Fertilization
• Artificial Insemination
• Surrogacy
• Others
On the basis on the procedure, this report focuses on the status and outlook for major applications, market share and growth rate for each application, including
• Frozen Donor
• Frozen Non Donor
• Fresh Donor
• Fresh Non Donor
• Embryo Banking
On the basis of end-user, the market has been segmented further, and displays growth rate and market share over the forecast period;
• Fertility Clinics
• Hospitals
• Others
Enquiry about Report@ www.qurateresearch.com/report/enquiry/HnM/QBI-XPR-HnM-55947
Geographic Segmentation: This report split global market into North America, Europe, Asia Pacific, the Middle East and Africa and Latin America, with revenue (Billion USD), market share and growth rate of assisted reproductive technology for these regions, from 2015 to 2025 (forecast)
• North America: U.S., Rest of North America
• Europe: Germany, France, UK, rest of Europe
• Asia Pacific: China, Japan, India and Rest of Asia Pacific
• Middle East & Africa: GCC, North Africa, South Africa and Rest of MEA
• Latin America: Brazil and Rest of Latin America
Contact Information:
Qurate Business Intelligence
Nehal Chinoy
Tel: +919881074592
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Qurate Business Intelligence
Nehal Chinoy
Tel: +919881074592
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results